Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

Volume XXXIII, No. 5 - April 13, 2026

Allina Will Join Sutter and Focus on Digital Growth

Minnesota-based Allina Health’s plans to join Sutter Health in California would create a multi-regional integrated delivery network backed by a $2 billion push into digital and outpatient care. As has been illustrated by past agreements and mergers, clinical laboratories for Allina face uncertainty in terms of centralized core lab functions and how testing may shift […]

To access this post, you must purchase The Dark Report.

Allina Will Join Sutter and Focus on Digital Growth Read More »

Allina Will Join Sutter, Focus on Digital Growth

CEO SUMMARY: Minnesota-based Allina Health’s plans to join Sutter Health in California would create a multi-regional integrated delivery network backed by a $2 billion push into digital and outpatient care. As has been illustrated by past agreements and mergers, clinical laboratories for Allina face uncertainty in terms of centralized core lab functions and how testing

To access this post, you must purchase The Dark Report.

Allina Will Join Sutter, Focus on Digital Growth Read More »

There’s Good and Bad News about Allina-Sutter Deal

Allina Health, Sutter Health, diagnostic laboratories, integrated delivery network, IDN, artificial intelligence, AI, bot, RAND Journal of Economics, Diagnostic laboratories once again find themselves pondering a large deal among integrated delivery networks. This time it’s a proposal for Allina Health in Minnesota to join Sutter Health based in California. But there are pros and cons

To access this post, you must purchase The Dark Report.

There’s Good and Bad News about Allina-Sutter Deal Read More »

For IVD Companies, Tariff Refunds May Be a Long Haul

Following the US Supreme Court’s decision declaring certain tariffs illegal, the diagnostics industry has entered a murky period regarding potential refunds. For in vitro diagnostics (IVD) manufacturers who paid these tariffs under policies from President Donald Trump’s administration, there is confusion over when and how any refunds will be processed. Things are even less clear

To access this post, you must purchase The Dark Report.

For IVD Companies, Tariff Refunds May Be a Long Haul Read More »

Digital Pathology’s Next Wave May Be in Precision Medicine

We’ve noted before that the adoption of digital pathology has not been as swift or strong as originally predicted. Many factors contribute to that concern. This topic came up in a recent interview The Dark Report conducted with Imogen Fitt, principal analyst at Signify Research, which released its 2025 Digital Pathology World Report in November.

To access this post, you must purchase The Dark Report.

Digital Pathology’s Next Wave May Be in Precision Medicine Read More »

Tracking the Chain of Custody in Histopathology Labs

Despite increasing adoption of digital pathology systems, many histopathology laboratories remain mired in manual workflows in the critical pre-analytical phase, as specimens are collected and processed into slides. Such workflows are not only inefficient but also susceptible to human error and tissue degradation, which increases the odds of inaccurate diagnoses. They also create safety hazards

To access this post, you must purchase The Dark Report.

Tracking the Chain of Custody in Histopathology Labs Read More »

Why Labs Must Rethink Audit Readiness in 2026

CEO SUMMARY: Doing everything right is no longer enough to ensure claims are paid. With AI-driven audits on the rise, lab leaders must ensure their organizations can prove compliance—quickly, clearly, and consistently. Based on commentary from RCM experts Ann Lambrix and Darla Wanitschke, we provide a list of key questions that decision-makers should present to

To access this post, you must purchase The Dark Report.

Why Labs Must Rethink Audit Readiness in 2026 Read More »

Lab Fraudster Warned of ‘Bad Players’ in Old Interview

The audacity of some criminals can be startling. Using fraudulent reimbursement to buy expensive vehicles and mocking Medicare beneficiaries seem to be routine parts of the dishonesty playbook. Former NFL prospect Keith J. Gray, owner of two clinical laboratories in Texas, is just the latest example. On Feb. 19, a Dallas jury convicted Gray for

To access this post, you must purchase The Dark Report.

Lab Fraudster Warned of ‘Bad Players’ in Old Interview Read More »

April 13, 2026, Intelligence: Late-Breaking Lab News

Walk-in clinical laboratory testing is expanding access to diagnostic services in West Virginia, reflecting a shift toward consumer-driven healthcare, according to a March 14 report in the Charleston Gazette-Mail. Patients can bypass physician referrals to purchase routine tests directly from local medical centers, gaining faster results and greater control over their health. Across the country,

To access this post, you must purchase The Dark Report.

April 13, 2026, Intelligence: Late-Breaking Lab News Read More »

;